Literature DB >> 28413216

Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection.

Yuan Liu1,2, Jian Zheng1, Yinping Liu1, Liyan Wen1, Lei Huang3,4, Zheng Xiang1, Kwok-Tai Lam1, Aizhen Lv1, Huawei Mao1,5, Yu-Lung Lau1, Wenwei Tu6.   

Abstract

Natural killer (NK) cells are indispensable components of both the innate and adaptive immune response. However, their precise roles in the cross-talk between innate and adaptive immunity during influenza virus infection remain controversial. By comparing NK cell dynamics and activity under a sub-lethal dose and high dose of influenza virus infection, we showed that influenza virus PR8 directly infected NK cells during natural infection, which was consistent with our previous findings obtained from an in vitro investigation of human NK cells. The impairments in cytotoxicity and IFN-γ production by spleen NK cells following high-dose infection were accompanied by decreased virus-specific killing mediated by cytotoxic T lymphocytes (CTLs). Importantly, the weakened CTL activity could be reversed by adoptive transfer of spleen NK cells harvested from low-dose-infected mice but not healthy donors. Taken together, our data provide direct evidence supporting the contribution of NK cells to antiviral T-cell responses. This study also indicates that a novel NK-targeted immune evasion strategy is used by influenza virus to shrink both innate and adaptive immune responses.

Entities:  

Keywords:  CTL; NK cell; influenza

Mesh:

Year:  2017        PMID: 28413216      PMCID: PMC6203736          DOI: 10.1038/cmi.2017.10

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  41 in total

1.  NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses.

Authors:  Philippe Krebs; Michael J Barnes; Kristin Lampe; Karen Whitley; Keith S Bahjat; Bruce Beutler; Edith Janssen; Kasper Hoebe
Journal:  Blood       Date:  2009-04-30       Impact factor: 22.113

2.  NK cells exacerbate the pathology of influenza virus infection in mice.

Authors:  Gang Zhou; Shih Wei W Juang; Kevin P Kane
Journal:  Eur J Immunol       Date:  2013-03-06       Impact factor: 5.532

3.  A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo.

Authors:  Gina M Conenello; Jennifer R Tisoncik; Elizabeth Rosenzweig; Zsuzsanna T Varga; Peter Palese; Michael G Katze
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

4.  Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity.

Authors:  Michael D Stadnisky; Xuefang Xie; Ebony R Coats; Timothy N Bullock; Michael G Brown
Journal:  Blood       Date:  2011-03-23       Impact factor: 22.113

5.  NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Authors:  Monia Draghi; Achal Pashine; Bharati Sanjanwala; Ketevan Gendzekhadze; Claudia Cantoni; David Cosman; Alessandro Moretta; Nicholas M Valiante; Peter Parham
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

6.  A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression.

Authors:  Ilan Vaknin; Liora Blinder; Lynn Wang; Roi Gazit; Elena Shapira; Olga Genina; Mark Pines; Eli Pikarsky; Michal Baniyash
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

7.  The functional impairment of natural killer cells during influenza virus infection.

Authors:  Hailong Guo; Pawan Kumar; Thomas M Moran; Adolfo Garcia-Sastre; Yan Zhou; Subramaniam Malarkannan
Journal:  Immunol Cell Biol       Date:  2009-09-01       Impact factor: 5.126

8.  Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.

Authors:  Yasuko Hatta; Karen Hershberger; Kyoko Shinya; Sean C Proll; Richard R Dubielzig; Masato Hatta; Michael G Katze; Yoshihiro Kawaoka; M Suresh
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

9.  Reciprocal activating interaction between natural killer cells and dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Carla Nisii; Viviana Marchesini; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

10.  Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.

Authors:  Diego Piccioli; Silverio Sbrana; Emiliano Melandri; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  18 in total

1.  Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.

Authors:  Joselyn Rojas-Quintero; Xiaoyun Wang; Jennifer Tipper; Patrick R Burkett; Joaquin Zuñiga; Amit R Ashtekar; Francesca Polverino; Amit Rout; Ilyas Yambayev; Carmen Hernández; Luis Jimenez; Gustavo Ramírez; Kevin S Harrod; Caroline A Owen
Journal:  JCI Insight       Date:  2018-12-20

Review 2.  Challenges of NK cell-based immunotherapy in the new era.

Authors:  Fang Fang; Weihua Xiao; Zhigang Tian
Journal:  Front Med       Date:  2018-07-25       Impact factor: 4.592

3.  Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation via Toll-Like Receptor 7.

Authors:  Sabine Stegemann-Koniszewski; Sarah Behrens; Julia D Boehme; Inga Hochnadel; Peggy Riese; Carlos A Guzmán; Andrea Kröger; Jens Schreiber; Matthias Gunzer; Dunja Bruder
Journal:  Front Immunol       Date:  2018-02-13       Impact factor: 7.561

4.  Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-γ.

Authors:  Bailing Yan; Feng Chen; Lijun Xu; Yanshi Wang; Xuefu Wang
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

5.  Defective Influenza A Virus RNA Products Mediate MAVS-Dependent Upregulation of Human Leukocyte Antigen Class I Proteins.

Authors:  Mir Munir A Rahim; Brendon D Parsons; Denys A Khaperskyy; Craig McCormick; Andrew P Makrigiannis; Emma L Price; Patrick D Slaine; Becca L Chilvers; Gregory S Seaton; Andrew Wight; Daniel Medina-Luna; Sayanti Dey; Shannen L Grandy; Lauryn E Anderson; Natalia Zamorano Cuervo; Nathalie Grandvaux; Marta M Gaglia; Alyson A Kelvin
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

6.  Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells.

Authors:  Marlena Scharenberg; Sindhu Vangeti; Eliisa Kekäläinen; Per Bergman; Mamdoh Al-Ameri; Niclas Johansson; Klara Sondén; Sara Falck-Jones; Anna Färnert; Hans-Gustaf Ljunggren; Jakob Michaëlsson; Anna Smed-Sörensen; Nicole Marquardt
Journal:  Front Immunol       Date:  2019-05-17       Impact factor: 7.561

Review 7.  Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.

Authors:  Stanislaw Schmidt; Lars Tramsen; Bushra Rais; Evelyn Ullrich; Thomas Lehrnbecher
Journal:  Oncotarget       Date:  2018-04-17

8.  Natural Killer Cell Recruitment to the Lung During Influenza A Virus Infection Is Dependent on CXCR3, CCR5, and Virus Exposure Dose.

Authors:  Lindsey E Carlin; Emily A Hemann; Zeb R Zacharias; Jonathan W Heusel; Kevin L Legge
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

9.  CD137 costimulation enhances the antiviral activity of Vγ9Vδ2-T cells against influenza virus.

Authors:  Yujun Pei; Kun Wen; Zheng Xiang; Chunyu Huang; Xiwei Wang; Xiaofeng Mu; Liyan Wen; Yinping Liu; Wenwei Tu
Journal:  Signal Transduct Target Ther       Date:  2020-06-03

Review 10.  Liver-Mediated Adaptive Immune Tolerance.

Authors:  Meijuan Zheng; Zhigang Tian
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.